Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

Journal of Dermatological Science

Volumn 63, Issue 1, 2011, Pages 40-46

  Tsai, Tsen Fang ^a   Wang, Ting Shun ^a   Hung, Sheng Tzu ^b   Tsai, Phiona I Ching ^c   Schenkel, Brad ^d   Zhang, Mingliang ^d   Tang, Chao Hsiun ^b,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c Janssen Cilag Taiwan   (Taiwan)

^d Johnson and Johnson Pharmaceutical Services   (United States)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Claims data; Comorbidities; Epidemiology; Metabolic syndrome; National Health Insurance; Psoriasis; Taiwan

Indexed keywords

ADULT; AGED; ALLERGIC RHINITIS; ALOPECIA AREATA; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEART DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIP CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PEMPHIGOID; PEMPHIGUS; PERITONEUM CANCER; PHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SLEEP DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; VITILIGO;

ADULT; AGE DISTRIBUTION; AGED; AMBULATORY CARE; CASE-CONTROL STUDIES; COMORBIDITY; DATABASES AS TOPIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT ADMISSION; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 79957557452     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.03.002     Document Type: Article

References (53)

1. Raychaudhuri S.P., Farber E.M. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001, 15:16-17.
2. Chang Y.T., Chen T.J., Liu P.C., Chen Y.C., Chen Y.J., Huang Y.L., et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009, 89:262-266.
3. Schmitt J., Ford D.E. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2010, 24:885-892.
4. Wakkee M., Herings R.M., Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010, 130:962-967.
5. Ritchlin C. Psoriatic disease: from skin to bone. Nat Clin Pract Rheumatol 2007, 3:698-706.
6. National Health Research Institutes, [accessed 15.8.10]. http://w3.nhri.org.tw/nhird//en/index.htm.2010.08.16.
7. Hsiao F.Y., Yang C.L., Huang Y.T., Huang W.F. Using Taiwan's national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal 2007, 15:99-108.
8. Department of Statistics Ministry of the Interior Statistical yearbook: population by age, 2006 2008, Department of Statistics Ministry of the Interior, Taipei, Taiwan.
9. Stem R.S. Utilization of outpatient care for psoriasis. J Am Acad Dermatol 1996, 35:543-545.
10. Chen H.H., Tseng M.P., Tsai T.F. An epidemiologic study of Taiwanese psoriatic patients in a single clinic. Dermatol Sinica 2003, 21:216-224.
11. Kawada A., Tezuka T., Nakamizo Y., Kimura H., Nakagawa H., Ohkido M., et al. Japanese Society for Psoriasis Research. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci 2003, 31:59-64.
12. Khaleque K.A., Basit A. Study on psoriasis cases in East Pakistan. J Trop Med Hyg 1968, 71:20-23.
13. Chang C.C., Gangaram H.B., Hussein S.H. Malaysian Psoriasis Registry: preliminary report of a pilot study using a newly revised registry form. Med J Malaysia 2008, 63(Suppl. C):68-71.
14. Kaur I., Handa S., Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol 1997, 24:230-234.
15. Zhang X., Wang H., Te-Shao H., Yang S., Chen S. The genetic epidemiology of psoriasis vulgaris in Chinese Han. Int J Dermatol 2002, 41:663-669.
16. Department of Health, R.O.C. Health Statistics (IV): statistics on National Health Insurance. Rate of seeking outpatient services by major diseases, http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx%3Fnow_fod_list_no=11590%26class_no=440%26level_no=3.
17. Henseler T., Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995, 32:982-986.
18. Gupta M.A., Gupta A.K. Psychiatric and psychological comorbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003, 4:833-842.
19. Alsufyani M.A., Golant A.K., Lebwohl M. Psoriasis and the metabolic syndrome. Dermatol Ther 2010, 23:137-143.
20. Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B., Gelfand J.M. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006, 55:829-835.
21. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
22. Gelfand J.M., Shin D.B., Neimann A.L., Wang X., Margolis D.J., Troxel A.B. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006, 126:2194-2201.
23. Brauchli Y.B., Jick S.S., Miret M., Meier C.R. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 2009, 129:2604-2612.
24. Davidovici B.B., Sattar N., Prinz J.C., Puig L., Emery P., Barker J.N., et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010, 130:1785-1796.
25. Davidsson S., Blomqvist K., Molin L., Mørk C., Sigurgeirsson B., Zachariae H., et al. Lifestyle of Nordic people with psoriasis. Int J Dermatol 2005, 44:378-383.
26. Lotti T., Hercogova J., Prignano F. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?. Dermatol Ther 2010, 23:119-122.
27. Chouela E., Abeldaño A., Panetta J., Ducard M., Neglia V., Sookoian S., et al. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 1996, 35:797-799.
28. Cohen A.D., Weitzman D., Birkenfeld S., Dreiher J. Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology 2010, 220:218-222.
29. Taglione E., Vatteroni M.L., Martini P., Galluzzo E., Lombardini F., Delle Sedie A., et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 1999, 26:370-372.
30. Guadagnino V., Ayala F., Chirianni A., Picciotto L., Tiseo D., Piazza M. Risk of hepatitis B virus infection in patients with eczema or psoriasis of the hand. Br Med J (Clin Res Ed) 1982, 284:84.
31. Huang H.H., Shih W.L., Li Y.H., Wu C.F., Chen P.J., Lin C.L., et al. Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway. Gut 2011, 60:99-107.
32. Lin C.F., Twu S.J., Chen P.H., Cheng J.S., Wang J.D. Prevalence and determinants of hepatitis B antigenemia in 15,007 inmates in Taiwan. J Epidemiol 2010, 20:231-236.
33. Lazarczyk M., Wozniak K., Ishii N., Gorkiewicz-Petkov A., Hashimoto T., Schwarz R., Kowalewski C. Coexistence of psoriasis and pemphigoid: only a coincidence?. Int J Mol Med 2006, 18:619-623.
34. Masmoudi A., Hadj Taieb H., Ben Ayed M., Abida O., Makni H., Turki H., et al. Tunisian erythematosus pemphigus associated with psoriasis in two sisters. Ann Dermatol Venereol 2006, 133:184-185.
35. Caldarola G., Carbone A., De Simone C., Pellicano R. Development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine. J Am Acad Dermatol 2010, 63:356-357.
36. Fryer E.J., Lebwohl M. Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. J Am Acad Dermatol 1994, 30:651-653.
37. Zalla M.J., Muller S.A. The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders. Acta Derm Venereol 1996, 195(Suppl.):1-15.
38. Berthelot C., Nash J., Duvic M. Coexistent psoriasis and lupus erythematosus treated with alefacept. Am J Clin Dermatol 2007, 8:47-50.
39. Millns J.L., Muller S.A. The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases. Arch Dermatol 1980, 116(June):658-663.
40. Zhao X.F., Pan H.F., Yuan H., Zhang W.H., Li X.P., Wang G.H., et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 2010, 37:81-85.
41. Kaslow R.A. High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum 1982, 25:414-418.
42. Ferraccioli G.F., Assaloni R., Perin A. Drug-induced systemic lupus erythematosus and TNF-alpha blockers. Lancet 2002, 360:645.
43. Augustin M., Reich K., Glaeske G., Schaefer I., Radtke M. Comorbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010, 90:147-151.
44. Cohen A.D., Dreiher J., Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn's disease. J Eur Acad Dermatol Venereol 2009, 23:561-565.
45. Jenisch S., Hampe J., Elder J.T., Nair R., Stuart P., Voorhees J.J., et al. CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association. Arch Dermatol Res 2006, 297:409-411.
46. Plant D., Lear J., Marsland A., Worthington J., Griffiths C.E. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis. Br J Dermatol 2004, 151:675-678.
47. Nair R.P., Stuart P., Ogura Y., Inohara N., Chia N.V., Young L., et al. Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol 2001, 117:1671-1672.
48. Su W.W., Chen C.H., Lin H.H., Yang S.S., Chang T.T., Cheng K.S., et al. Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas. Hepatol Int 2009, 3:537-543.
49. Bassiouny D.A., Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 2010, Epub ahead of print.
50. Arakawa M., Dainichi T., Yasumoto S., Hashimoto T. Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus. J Dermatol Sci 2009, 53:228-231.
51. Figueroa-Vega N., Alfonso-Pérez M., Benedicto I., Sánchez-Madrid F., González-Amaro R., Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2010, 95:953-962.
52. Veny M., Esteller M., Ricart E., Piqué J.M., Panés J., Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010, 31:561-572.
53. Toosi S., Bystryn J.C. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid. Med Hypotheses 2010, 74:727-728.